Boston An independent LDT provider

Board of directors

Chairman

Carl Borrebaeck

Professor Carl Borrebaeck is a successful entrepreneur and founder of Immunovia, who also founded Senzagen AB (Publ.) (SENZA; Nasdaq First North), BioInvent International AB (Publ.)…

Read more

Hans Johansson

Hans Johansson holds an M.Sc. (Eng.) in chemical engineering and has long-term experience and a broad-based contact network from previous roles in the life science…

Read more

Peter Høngaard Andersen

Dr. Peter Høngaard Andersen holds a B.Sc. in Chemistry, an M.Sc. in Biochemistry, is an M.D. and has many years’ experience and a broad network…

Read more

Martin Møller

Martin Møller has broad and deep experience in the international healthcare industry from more than 20 years at McKinsey & Company, a global management consultancy,…

Read more

Philipp von Hugo

Dr. Philipp von Hugo is an experienced international lawyer who currently serves as Vice President, Head of Global Legal Affairs and Compliance, at QIAGEN N.V,…

Read more

Eric Krafft

Eric Krafft is since 15 years an active private investor across several different industries. He currently serves on the boards of two public companies: Leading…

Read more